{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:41:41Z","timestamp":1788878501176,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82170728"],"award-info":[{"award-number":["No.82170728"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82070834"],"award-info":[{"award-number":["No.82070834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82073843"],"award-info":[{"award-number":["No.82073843"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY19H05001"],"award-info":[{"award-number":["LY19H05001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with salt-sensitive hypertension are often accompanied with severe renal damage and accelerate to end-stage renal disease, which currently lacks effective treatment. Fibroblast growth factor 21 (FGF21) has been shown to suppress nephropathy in both type 1 and type 2 diabetes mice. Here, we aimed to investigate the therapeutic effect of FGF21 in salt-sensitive hypertension-induced nephropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Changes of FGF21 expression in deoxycorticosterone acetate (DOCA)-salt-induced hypertensive mice were detected. The influence of FGF21 knockout in mice on DOCA-salt-induced nephropathy were determined. Recombinant human FGF21 (rhFGF21) was intraperitoneally injected into DOCA-salt-induced nephropathy mice, and then the inflammatory factors, oxidative stress levels and kidney injury-related indicators were observed. In vitro, human renal tubular epithelial cells (HK-2) were challenged by palmitate acid (PA) with or without FGF21, and then changes in inflammation and oxidative stress indicators were tested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed significant elevation in circulating levels and renal expression of FGF21 in DOCA-salt-induced hypertensive mice. We found that deletion of FGF21 in mice aggravated DOCA-salt-induced nephropathy. Supplementation with rhFGF21 reversed DOCA-salt-induced kidney injury. Mechanically, rhFGF21 induced AMPK activation in DOCA-salt-treated mice and PA-stimulated HK-2 cells, which inhibited NF-\u03baB-regulated inflammation and Nrf2-mediated oxidative stress and thus, is important for rhFGF21 protection against DOCA-salt-induced nephropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings indicated that rhFGF21 could be a promising pharmacological strategy for the treatment of salt-sensitive hypertension-induced nephropathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-021-00408-x","type":"journal-article","created":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T07:02:59Z","timestamp":1636786979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism"],"prefix":"10.1186","volume":"27","author":[{"given":"Hua-Chun","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Sheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0697-5100","authenticated-orcid":false,"given":"Hong-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,13]]},"reference":[{"issue":"4","key":"408_CR1","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/HYPERTENSIONAHA.119.12927","volume":"74","author":"JM Abais-Battad","year":"2019","unstructured":"Abais-Battad JM, Alsheikh AJ, Pan X, Fehrenbach DJ, Dasinger JH, Lund H, Roberts ML, Kriegel AJ, Cowley AW Jr, Kidambi S, Kotchen TA, Liu P, Liang M, Mattson DL. Dietary effects on Dahl salt-sensitive hypertension, renal damage, and the T lymphocyte transcriptome. Hypertension. 2019;74(4):854\u201363. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.12927.","journal-title":"Hypertension"},{"issue":"1","key":"408_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41467-020-14384-z","volume":"11","author":"S Byun","year":"2020","unstructured":"Byun S, Seok S, Kim YC, Zhang Y, Yau P, Iwamori N, Xu HE, Ma J, Kemper B, Kemper JK. Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. Nat Commun. 2020;11(1):807. https:\/\/doi.org\/10.1038\/s41467-020-14384-z.","journal-title":"Nat Commun"},{"key":"408_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2017.01.005","author":"D Carling","year":"2017","unstructured":"Carling D. AMPK signalling in health and disease. Curr Opin Cell Biol. 2017. https:\/\/doi.org\/10.1016\/j.ceb.2017.01.005.","journal-title":"Curr Opin Cell Biol"},{"key":"408_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.02.002","author":"Y Cheng","year":"2016","unstructured":"Cheng Y, Zhang J, Guo W, Li F, Sun W, Chen J, Zhang C, Lu X, Tan Y, Feng W, Fu Y, Liu GC, Xu Z, Cai L. Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy. Free Radic Biol Med. 2016. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.02.002.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"408_CR5","doi-asserted-by":"publisher","first-page":"12727","DOI":"10.3390\/molecules190812727","volume":"19","author":"BH Choi","year":"2014","unstructured":"Choi BH, Kang KS, Kwak MK. Effect of redox modulating NRF2 activators on chronic kidney disease. Molecules. 2014;19(8):12727\u201359. https:\/\/doi.org\/10.3390\/molecules190812727.","journal-title":"Molecules"},{"issue":"40","key":"408_CR6","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.2174\/1381612825666190112165206","volume":"24","author":"G Coppolino","year":"2018","unstructured":"Coppolino G, Leonardi G, Andreucci M, Bolignano D. Oxidative Stress and Kidney Function: A Brief Update. Curr Pharm Des. 2018;24(40):4794\u20139. https:\/\/doi.org\/10.2174\/1381612825666190112165206.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"408_CR7","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1111\/jcmm.16369","volume":"25","author":"Q Dai","year":"2021","unstructured":"Dai Q, Fan X, Meng X, Sun S, Su Y, Ling X, Chen X, Wang K, Dai X, Zhang C, Da S, Zhang G, Gu C, Chen H, He J, Hu H, Yu L, Pan X, Tan Y, Yan X. FGF21 promotes ischaemic angiogenesis and endothelial progenitor cells function under diabetic conditions in an AMPK\/NAD+-dependent manner. J Cell Mol Med. 2021;25(6):3091\u2013102. https:\/\/doi.org\/10.1111\/jcmm.16369.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"408_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/1440-1681.13042","volume":"46","author":"H Ding","year":"2019","unstructured":"Ding H, Zhou Y, Huang H. MiR-101a ameliorates AngII-mediated hypertensive nephropathy by blockade of TGFbeta\/Smad3 and NF-kappaB signalling in a mouse model of hypertension. Clin Exp Pharmacol Physiol. 2019;46(3):246\u201354. https:\/\/doi.org\/10.1111\/1440-1681.13042.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"408_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/10641963.2020.1836191","volume":"43","author":"Z Farooqui","year":"2021","unstructured":"Farooqui Z, Mohammad RS, Lokhandwala MF, Banday AA. Nrf2 inhibition induces oxidative stress, renal inflammation and hypertension in mice. Clin Exp Hypertens. 2021;43(2):175\u201380. https:\/\/doi.org\/10.1080\/10641963.2020.1836191.","journal-title":"Clin Exp Hypertens"},{"issue":"10","key":"408_CR10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jacc.2021.01.014","volume":"77","author":"N Fatani","year":"2021","unstructured":"Fatani N, Dixon DL, Van Tassell BW, Fanikos J, Buckley LF. Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension. J Am Coll Cardiol. 2021;77(10):1290\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2021.01.014.","journal-title":"J Am Coll Cardiol"},{"key":"408_CR11","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20200661","author":"M Gao","year":"2020","unstructured":"Gao M, Hu F, Hu M, Hu Y, Shi H, Zhao GJ, Jian C, Ji YX, Zhang XJ, She ZG, Li H, Zhu L. Sophoricoside ameliorates cardiac hypertrophy by activating AMPK\/mTORC1-mediated autophagy. 2020. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20200661."},{"issue":"9","key":"408_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.disamonth.2015.07.003","volume":"61","author":"R Gargiulo","year":"2015","unstructured":"Gargiulo R, Suhail F, Lerma EV. Hypertension and chronic kidney disease. Dis Mon. 2015;61(9):387\u201395. https:\/\/doi.org\/10.1016\/j.disamonth.2015.07.003.","journal-title":"Dis Mon"},{"issue":"11","key":"408_CR13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","volume":"16","author":"L Geng","year":"2020","unstructured":"Geng L, Lam KSL, Xu A. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Rev Endocrinol. 2020;16(11):654\u201367. https:\/\/doi.org\/10.1038\/s41574-020-0386-0.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"408_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.freeradbiomed.2011.09.015","volume":"52","author":"M Gomez-Guzman","year":"2012","unstructured":"Gomez-Guzman M, Jimenez R, Sanchez M, Zarzuelo MJ, Galindo P, Quintela AM, Lopez-Sepulveda R, Romero M, Tamargo J, Vargas F, Perez-Vizcaino F, Duarte J. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic Biol Med. 2012;52(1):70\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.09.015.","journal-title":"Free Radic Biol Med"},{"issue":"16","key":"408_CR15","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1517\/14656566.2010.485612","volume":"11","author":"PD Hart","year":"2010","unstructured":"Hart PD, Bakris GL. Hypertensive nephropathy: prevention and treatment recommendations. Expert Opin Pharmacother. 2010;11(16):2675\u201386. https:\/\/doi.org\/10.1517\/14656566.2010.485612.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"408_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121\u201335. https:\/\/doi.org\/10.1038\/nrm.2017.95.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"408_CR17","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/s41440-019-0332-5","volume":"42","author":"D Hirohama","year":"2019","unstructured":"Hirohama D, Fujita T. Evaluation of the pathophysiological mechanisms of salt-sensitive hypertension. Hypertens Res. 2019;42(12):1848\u201357. https:\/\/doi.org\/10.1038\/s41440-019-0332-5.","journal-title":"Hypertens Res"},{"key":"408_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172797","author":"R Hu","year":"2020","unstructured":"Hu R, Wang MQ, Ni SH, Wang M, Liu LY, You HY, Wu XH, Wang YJ, Lu L, Wei LB. Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK\/NF-kappaB\/NLRP3 signaling pathway in AGEs-induced HUVECs. Eur J Pharmacol. 2020. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172797.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"408_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11906-017-0730-5","volume":"19","author":"Z Huang","year":"2017","unstructured":"Huang Z, Xu A, Cheung BMY. The potential role of fibroblast growth factor 21 in lipid metabolism and hypertension. Curr Hypertens Rep. 2017;19(4):28. https:\/\/doi.org\/10.1007\/s11906-017-0730-5.","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"408_CR20","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","volume":"25","author":"A Kauppinen","year":"2013","unstructured":"Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 2013;25(10):1939\u201348. https:\/\/doi.org\/10.1016\/j.cellsig.2013.06.007.","journal-title":"Cell Signal"},{"issue":"6","key":"408_CR21","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. https:\/\/doi.org\/10.1101\/cshperspect.a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"408_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00662","author":"L Lei","year":"2020","unstructured":"Lei L, Chai Y, Lin H, Chen C, Zhao M, Xiong W, Zhuang J, Fan X. Dihydroquercetin activates AMPK\/Nrf2\/HO-1 signaling in macrophages and attenuates inflammation in LPS-induced endotoxemic mice. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.00662.","journal-title":"Front Pharmacol"},{"issue":"8","key":"408_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tem.2019.05.007","volume":"30","author":"JE Lewis","year":"2019","unstructured":"Lewis JE, Ebling FJP, Samms RJ, Tsintzas K. Going back to the biology of FGF21: new insights. Trends Endocrinol Metab. 2019;30(8):491\u2013504. https:\/\/doi.org\/10.1016\/j.tem.2019.05.007.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"408_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","volume":"27","author":"SC Lin","year":"2018","unstructured":"Lin SC, Hardie DG. AMPK: sensing glucose as well as cellular energy status. Cell Metab. 2018;27(2):299\u2013313. https:\/\/doi.org\/10.1016\/j.cmet.2017.10.009.","journal-title":"Cell Metab"},{"issue":"21","key":"408_CR25","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","volume":"131","author":"Z Lin","year":"2015","unstructured":"Lin Z, Pan X, Wu F, Ye D, Zhang Y, Wang Y, Jin L, Lian Q, Huang Y, Ding H, Triggle C, Wang K, Li X, Xu A. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice. Circulation. 2015;131(21):1861\u201371. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015308.","journal-title":"Circulation"},{"issue":"1","key":"408_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12944-019-1093-5","volume":"18","author":"ZX Liu","year":"2019","unstructured":"Liu ZX, Hong Q, Peng DH, Yang Y, Yu WL, Shui H, Zhou X, Liu SM. Evaluation of serum free fatty acids in chronic renal failure: evidence from a rare case with undetectable serum free fatty acids and population data. Lipids Health Dis. 2019;18(1):151. https:\/\/doi.org\/10.1186\/s12944-019-1093-5.","journal-title":"Lipids Health Dis"},{"issue":"12","key":"408_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11906-018-0903-x","volume":"20","author":"X Lu","year":"2018","unstructured":"Lu X, Crowley SD. Inflammation in salt-sensitive hypertension and renal damage. Curr Hypertens Rep. 2018;20(12):103. https:\/\/doi.org\/10.1007\/s11906-018-0903-x.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"408_CR28","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/jcmm.14863","volume":"24","author":"C Lu","year":"2020","unstructured":"Lu C, Chen B, Chen C, Li H, Wang D, Tan Y, Weng H. CircNr1h4 regulates the pathological process of renal injury in salt-sensitive hypertensive mice by targeting miR-155\u20135p. J Cell Mol Med. 2020;24(2):1700\u201312. https:\/\/doi.org\/10.1111\/jcmm.14863.","journal-title":"J Cell Mol Med"},{"key":"408_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101393","author":"M Matzinger","year":"2020","unstructured":"Matzinger M, Fischhuber K, P\u00f6l\u00f6ske D, Mechtler K, Heiss EH. AMPK leads to phosphorylation of the transcription factor Nrf2, tuning transactivation of selected target genes. Redox Biol. 2020. https:\/\/doi.org\/10.1016\/j.redox.2019.101393.","journal-title":"Redox Biol"},{"key":"408_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9605980","author":"YL Ni","year":"2019","unstructured":"Ni YL, Shen HT, Su CH, Chen WY, Huang-Liu R, Chen CJ, Chen SP, Kuan YH. Nerolidol suppresses the inflammatory response during lipopolysaccharide-induced acute lung injury via the modulation of antioxidant enzymes and the AMPK\/Nrf-2\/HO-1 pathway. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/9605980.","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"408_CR31","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00125-015-3652-2","volume":"58","author":"KL Ong","year":"2015","unstructured":"Ong KL, Januszewski AS, O\u2019Connell R, Buizen L, Jenkins AJ, Xu A, Sullivan DR, Barter PJ, Scott RS, Taskinen MR, Rye KA, Keech AC. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia. 2015;58(9):2035\u201344. https:\/\/doi.org\/10.1007\/s00125-015-3652-2.","journal-title":"Diabetologia"},{"issue":"6","key":"408_CR32","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cmet.2018.04.002","volume":"27","author":"X Pan","year":"2018","unstructured":"Pan X, Shao Y, Wu F, Wang Y, Xiong R, Zheng J, Tian H, Wang B, Wang Y, Zhang Y, Han Z, Qu A, Xu H, Lu A, Yang T, Li X, Xu A, Du J, Lin Z. FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2\/angiotensin-(1\u20137) axis in mice. Cell Metab. 2018;27(6):1323\u201337. https:\/\/doi.org\/10.1016\/j.cmet.2018.04.002.","journal-title":"Cell Metab"},{"key":"408_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2016_147","author":"P Rust","year":"2017","unstructured":"Rust P, Ekmekcioglu C. Impact of salt intake on the pathogenesis and treatment of hypertension. Adv Exp Med Biol. 2017. https:\/\/doi.org\/10.1007\/5584_2016_147.","journal-title":"Adv Exp Med Biol"},{"key":"408_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154738","author":"JV Salgado","year":"2021","unstructured":"Salgado JV, Goes MA, Salgado FN. FGF21 and chronic kidney disease. Metabolism. 2021. https:\/\/doi.org\/10.1016\/j.metabol.2021.154738.","journal-title":"Metabolism"},{"issue":"2","key":"408_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3109\/10641960902993111","volume":"32","author":"B Seifi","year":"2010","unstructured":"Seifi B, Kadkhodaee M, Karimian SM, Zahmatkesh M, Xu J, Soleimani M. Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage. Clin Exp Hypertens. 2010;32(2):90\u20137. https:\/\/doi.org\/10.3109\/10641960902993111.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"408_CR36","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.1152\/ajpendo.00026.2015","volume":"309","author":"M Shao","year":"2015","unstructured":"Shao M, Yu L, Zhang F, Lu X, Li X, Cheng P, Lin X, He L, Jin S, Tan Y, Yang H, Zhang C, Cai L. Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model. Am J Physiol Endocrinol Metab. 2015;309(1):E45-54. https:\/\/doi.org\/10.1152\/ajpendo.00026.2015.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"408_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1573402111666150529130922","volume":"11","author":"N Sinha","year":"2015","unstructured":"Sinha N, Dabla PK. Oxidative stress and antioxidants in hypertension-a current review. Curr Hypertens Rev. 2015;11(2):132\u201342. https:\/\/doi.org\/10.2174\/1573402111666150529130922.","journal-title":"Curr Hypertens Rev"},{"issue":"3","key":"408_CR38","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ndt\/gfr402","volume":"27","author":"MC Slagman","year":"2012","unstructured":"Slagman MC, Kwakernaak AJ, Yazdani S, Laverman GD, van den Born J, Titze J, Navis G. Vascular endothelial growth factor C levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects. Nephrol Dial Transpl. 2012;27(3):978\u201382. https:\/\/doi.org\/10.1093\/ndt\/gfr402.","journal-title":"Nephrol Dial Transpl"},{"key":"408_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.154002","author":"Y Sun","year":"2020","unstructured":"Sun Y, Zhou S, Guo H, Zhang J, Ma T, Zheng Y, Zhang Z, Cai L. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function. Metabolism. 2020. https:\/\/doi.org\/10.1016\/j.metabol.2019.154002.","journal-title":"Metabolism"},{"key":"408_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00419","author":"C Tezze","year":"2019","unstructured":"Tezze C, Romanello V, Sandri M. FGF21 as modulator of metabolism in health and disease. Front Physiol. 2019. https:\/\/doi.org\/10.3389\/fphys.2019.00419.","journal-title":"Front Physiol"},{"issue":"5","key":"408_CR41","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/HYPERTENSIONAHA.114.04094","volume":"64","author":"H Weng","year":"2014","unstructured":"Weng H, Ji X, Endo K, Iwai N. Pex11a deficiency is associated with a reduced abundance of functional peroxisomes and aggravated renal interstitial lesions. Hypertension. 2014;64(5):1054\u201360. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04094.","journal-title":"Hypertension"},{"issue":"3","key":"408_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/jdi.13179","volume":"11","author":"H Yamakage","year":"2020","unstructured":"Yamakage H, Tanaka M, Inoue T, Odori S, Kusakabe T, Satoh-Asahara N. Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: a randomized, controlled trial. J Diabetes Investig. 2020;11(3):653\u201361. https:\/\/doi.org\/10.1111\/jdi.13179.","journal-title":"J Diabetes Investig."},{"issue":"6","key":"408_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.anai.2021.02.019","volume":"126","author":"K Yamamoto-Hanada","year":"2021","unstructured":"Yamamoto-Hanada K, Pak K, Saito-Abe M, Sato M, Ohya Y, Japan E. Better maternal quality of life in pregnancy yields better offspring respiratory outcomes: a birth cohort. Ann Allergy Asthma Immunol. 2021;126(6):713\u201321. https:\/\/doi.org\/10.1016\/j.anai.2021.02.019.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"408_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113534","author":"Y Yan","year":"2018","unstructured":"Yan Y, Zhou XE, Xu HE, Melcher K. Structure and physiological regulation of AMPK. Int J Mol Sci. 2018a. https:\/\/doi.org\/10.3390\/ijms19113534.","journal-title":"Int J Mol Sci"},{"key":"408_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8472963","author":"D Yan","year":"2018","unstructured":"Yan D, Yue B, Qian M, Zhao L, Zhang Z, Qian H, Yan S, Qian Y, Fang Z. JYYS granule mitigates renal injury in clinic and in spontaneously hypertensive rats by inhibiting NF-kappaB signaling-mediated microinflammation. Evid Based Complement Alternat Med. 2018b. https:\/\/doi.org\/10.1155\/2018\/8472963.","journal-title":"Evid Based Complement Alternat Med."},{"issue":"2","key":"408_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41419-018-0307-5","volume":"9","author":"H Yang","year":"2018","unstructured":"Yang H, Feng A, Lin S, Yu L, Lin X, Yan X, Lu X, Zhang C. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart. Cell Death Dis. 2018;9(2):227. https:\/\/doi.org\/10.1038\/s41419-018-0307-5.","journal-title":"Cell Death Dis"},{"issue":"3","key":"408_CR47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s12020-014-0503-8","volume":"49","author":"X Ye","year":"2015","unstructured":"Ye X, Qi J, Ren G, Xu P, Wu Y, Zhu S, Yu D, Li S, Wu Q, Muhi RL, Li D. Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice. Endocrine. 2015;49(3):683\u201392. https:\/\/doi.org\/10.1007\/s12020-014-0503-8.","journal-title":"Endocrine"},{"key":"408_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4717258","author":"J Yu","year":"2020","unstructured":"Yu J, Wang WN, Matei N, Li X, Pang JW, Mo J, Chen SP, Tang JP, Yan M, Zhang JH. Ezetimibe attenuates oxidative stress and neuroinflammation via the AMPK\/Nrf2\/TXNIP pathway after MCAO in rats. Oxid Med Cell Longev. 2020. https:\/\/doi.org\/10.1155\/2020\/4717258.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"408_CR49","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/CS20150623","volume":"130","author":"J Zhang","year":"2016","unstructured":"Zhang J, Cheng Y, Gu J, Wang S, Zhou S, Wang Y, Tan Y, Feng W, Fu Y, Mellen N, Cheng R, Ma J, Zhang C, Li Z, Cai L. Fenofibrate increases cardiac autophagy via FGF21\/SIRT1 and prevents fibrosis and inflammation in the hearts of type 1 diabetic mice. Clin Sci (lond). 2016;130(8):625\u201341. https:\/\/doi.org\/10.1042\/CS20150623.","journal-title":"Clin Sci (lond)"},{"issue":"9","key":"408_CR50","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.7150\/ijbs.25026","volume":"14","author":"J Zhang","year":"2018","unstructured":"Zhang J, Weng W, Wang K, Lu X, Cai L, Sun J. The role of FGF21 in type 1 diabetes and its complications. Int J Biol Sci. 2018;14(9):1000\u201311. https:\/\/doi.org\/10.7150\/ijbs.25026.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"408_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.23736\/S0031-0808.19.03649-8","volume":"62","author":"W Zhang","year":"2020","unstructured":"Zhang W, Cheng B, Lu Q, Sheng Y, Sun X, Chen X. Analysis of the correlations of hypertension complicated with or without hypertensive nephropathy with glucose and lipid metabolism, vascular endothelial function, inflammation, oxidative stress and course of disease. Panminerva Med. 2020;62(3):180\u20133. https:\/\/doi.org\/10.23736\/S0031-0808.19.03649-8.","journal-title":"Panminerva Med"},{"issue":"10","key":"408_CR52","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/15384101.2020.1743911","volume":"19","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Bian Y, Zhang Y, Ren G, Li G. Metformin activates AMPK\/SIRT1\/NF-\u03baB pathway and induces mitochondrial dysfunction to drive caspase3\/GSDME-mediated cancer cell pyroptosis. Cell Cycle. 2020;19(10):1089\u2013104. https:\/\/doi.org\/10.1080\/15384101.2020.1743911.","journal-title":"Cell Cycle"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-021-00408-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T19:12:00Z","timestamp":1636830720000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-021-00408-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,13]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1186\/s10020-021-00408-x","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-820707\/v1","asserted-by":"object"}]},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,13]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Animal Experimental Ethical Inspection of Laboratory Animal Centre of Wenzhou Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests regarding the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}